Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

NCT03341637 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda